RTW Investments’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

RTW Investments’s Portfolio CEREW Stock Details CEREW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-166,666	Closed	-$2.4M	–	130
2021 Q2	$2.4M	Hold	166,666	–	–	0.04%	104
2021 Q1	$718K	Hold	166,666	–	–	0.01%	107
2020 Q4	$942K	Buy	+166,666	New	+$672K	0.02%	97

RTW Investments's CEREW Position: Q3 2021 in Review

RTW Investments sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 166,666 shares — an estimated $2.4M sold.

RTW Investments first reported a position in CEREW in Q4 2020 and held it in 3 quarters. The position peaked at $2.4M in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

RTW Investments reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
RTW Investments sold 166,666 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $2.4M.
RTW Investments first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 3 quarters.
RTW Investments's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $2.4M in Q2 2021.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on RTW Investments's 13F filing for Q3 2021, filed 15 Nov 2021.